Introducing NVIDIA’s “first big bet” on the digital biology revolution, NVIDIA CEO Jensen Huang Wednesday unveiled Cambridge-1, a $100 million investment that promises to harness partnerships across the U.K. for breakthroughs with a “global impact.” The U.K.’s most powerful supercomputer, Cambridge-1 will advance research at AstraZeneca, GSK, King’s College London, Oxford Nanopore, and Guy’s and Read article >
The post NVIDIA CEO Unveils ‘First Big Bet’ on Digital Biology Revolution with UK-Based Cambridge-1 appeared first on The Official NVIDIA Blog.